Another possible limitation is that a few false-positives of MCM4 ICC with benign cases were present in this study, so the application of MCM4 would be ideal for use as an adjunct to cytomorphology-based diagnosis. This evidence concerns the gene MCM4 and intrahepatic cholangiocarcinoma.